Sodium channel kinetic changes that produce Brugada syndrome or progressive cardiac conduction system disease

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 292, Issue 1, 2007, Pages

  Zhang, Zhu Shan ^a   Tranquillo, Joseph ^c   Neplioueva, Valentina ^a   Bursac, Nenad ^b   Grant, Augustus O ^a,d  

^a DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Duke University   (United States)

^c BUCKNELL UNIVERSITY   (United States)

^d DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Brugada syndrome; Conduction system disease; Sodium channel

Indexed keywords

LYSINE; SODIUM CHANNEL;

ARTICLE; BRUGADA SYNDROME; CONTROLLED STUDY; ELECTROCARDIOGRAPHY; GENE MUTATION; HUMAN; HUMAN CELL; PHENOTYPE; PRIORITY JOURNAL; PROGRESSIVE CARDIAC CONDUCTION DEFECT; SODIUM CURRENT; ST SEGMENT ELEVATION;

ACTION POTENTIALS; BRUGADA SYNDROME; CELL LINE; COMPUTER SIMULATION; HEART CONDUCTION SYSTEM; HUMANS; ION CHANNEL GATING; KIDNEY; KINETICS; MODELS, CARDIOVASCULAR; MUSCLE PROTEINS; MUTATION; PRE-EXCITATION SYNDROMES; SODIUM CHANNELS; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 33846225256     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.01025.2005     Document Type: Article

References (27)

1. Akai J, Makita N, Sakurada H, Shirai N, Ueda K, Kitabatake A, Nakazawa K, Kimura A, and Hiraoka M. A novel SCN5A mutation associated with idiopathic ventricular fibrillation without typical ECG findings of Brugada syndrome. FEBS Lett 479: 29-34, 2000.
2. Antzelevitch C, Brugada P, Brugada J, Brugada R, Towbin JA, and Nademancee K. Brugada syndrome: 1992-2002. J Am Coll Cardiol 41: 1665-1671, 2003.
3. Chen Q, Kirsch GE, Zhang D, Brugada R, Brugada J, Brugada P, Potenza D, Moya A, Borggrefe M, Breithardt G, Prtoz-Lopez R, Wang Z, Antzelevitch C, Brien REO, Schulze-Bahr E, Keating MT, Towbin JA, and Wang Q. Genetic basis and molecular mechanism for idiopathic ventricular fibrillation. Nature 392: 293-296, 1998.
4. Coronel R, Casini S, Koopmann TT, Wilms-Schopman FJG, Verkerk AO, de Groot JR, Bhuiyan Z, Bezzina CR, Veldkamp MW, Linnenbank AC, van der Wal AC, Tan HL, Brugada P, Wilde AAM, and de Bakker JMT. Right ventricular fibrosis and conduction delay in a patient with clinical signs of Brugada syndrome: a combined electrophysiological, genetic, histopathologic, and computational study. Circulation 112: 2769-2777, 2005.
5. Dumaine R, Towbin JA, Brugada P, Vatta M, Nesterenko DV, Nesterenko VV, Brugada J, Brugada R, and Antzelevitch C. Ionic mechanisms responsible for the electrocardiographic phenotype of the Brugada syndrome are temperature dependent. Circ Res 85: 803-809, 1999.
6. Fozzard H and Hanck DA. Structure and function of voltage-dependent sodium channels: Comparison of brain II and cardiac isoforms. Physiol Rev 76: 887-926, 1996.
7. Gilliam FRI, Starmer CF, and Grant AO. Blockade of rabbit atrial sodium channels by lidocaine: Characterization of continuous and frequency-dependent blocking. Circ Res 65: 723-739, 1989.
8. Gima K and Rudy Y. Ionic current basis of electrocardiographic waveforms. Circ Res 90: 889-896, 2002.
9. Grant AO, Carboni MP, Neplioueva V, Starmer CF, Memmi M, Napolitano C, and Priori S. Long QT syndrome, Brugada syndrome, and conduction system disease are linked to a single sodium channel mutation. J Clin Invest 110: 1201-1209, 2002.
10. Gussak I, Antzelevitch C, Bjerregaard P, Towbin JA, and Chaitman BR. The Brugada syndrome: clinical, electrophysiologic and genetic aspects. J Am Coll Cardiol 33: 5-15, 1999.
11. Hamill OP, Marty A, Neher E, Sakmann B, and Sigworth F. Improved patch-clamp techniques for high-resolution current recording from cell and cell-free membrane patches. Pflugers Arch 391: 85-100, 1981.
12. Higuchi R. Recombinant PCR. In: PCR Protocols: A Guide to Methods and Applications, edited by Innis MA. San Diego, CA: Academic, 1990, p. 177-183.
13. Hodgkin AL and Huxley AF. The dual effect of membrane potential on sodium conductance in the giant axon of loligo. J Physiol 116: 497-506, 1952.
14. Kyndt F, Probst V, Potet F, Demolombe S, Chevallier JC, Baro I, Moisan JP, Boisseau P, Schott JJ, Escande D, and Marec HL. Novel SCN5A mutation leading either to isolated cardiac conduction defect or Brugada syndrome in a large French family. Circulation 104: 3081-3086, 2001.
15. Moric E, Herbert E, Trusz-Gluza M, Filipecki A, Mazurek U, and Wilczok T. The implications of genetic mutations in the sodium channel gene (SCN5A). Europace 5: 325-334, 2003.
16. +-channel inactivation: Charge neutralizations and deletions in the III-IV linker. Proc Natl Acad Sci USA 89: 10905-10909, 1992.
17. Pitzalis MV, Anaclerio M, Mastropasqua F, Sorrentino S, Manghisi A, and Rizzon P. QT-interval prolongation inright precordial leads: an additional electrocardiographic hallmark of Brugada syndrome. J Am Coll Cardiol 42: 1632-1637, 2003.
18. Plonsey R and Barr RC. Extracellular fields. In: Bioelectricity: A Quantitative Approach. New York: Plenum, 2000, p. 217-243.
19. Probst V, Allouis M, Sacher F, Pattier S, Babuty D, Mabo P, Mansourati J, Victor J, Nguyen JM, Schott JJ, Boisseau P, Escande D, and Le Marec H. Progressive cardiac conduction defect is the prevailing phenotype in carriers of a Brugada syndrome SCN5A mutation. J Cardiovasc Electrophysiol 17: 270-275, 2006.
20. Rohl CA, Boeckman FA, Baker C, Scheuer T, Catterall WA, and Klevit RE. Solution structure of the sodium channel inactivation gate. Biochemistry 38: 855-861, 1999.
21. Schott JJ, Alshinawi C, and Kyndt F. Cardiac conduction defects associate with mutations in SCN5A. Nature Genet 23: 20-21, 1999.
22. Schulze-Bahr E, Eckardt L, Breithardt G, Seidl K, Wichter T, Wolpert C, Borggrefe M, and Haverkamp W. Sodium channel gene (SCN5A) mutations in 44 index patients with Brugada syndrome: different incidences in familial and sporadic disease. Human Mutation 21: 651-652, 2003.
23. Sirota FL, Pascutti PG, and Anteneoda C. Molecular modeling and dynamics of the sodium channel inactivation gate. Biophys J 82: 1207-1215, 2002.
24. Smits JP, Eckardt L, Probst V, Bezzina CR, Schott JJ, Remme CA, Haverkamp W, Breithardt G, Escande D, Schulze-Bahr E, LeMarec H, and Wilde AA. Genotype-phenotype relationship in Brugada syndrome: electrocardiographic features differentiate SCN5A-related patients from non-SCN5A-related patients. J Am Coll Cardiol 40: 350-356, 2002.
25. Tan H, Bink-Boelkens M, Bezzina C, Viswanathan P, Beaufort-Krol G, van Tinteien P, van den Berg M, Wilde A, and Balser J. A sodium-channel mutation causes isolated cardiac conduction disease. Nature 409: 1043-1047, 2001.
26. Ks heterogeneity on action potential duration and its rate dependence. Circulation 99: 2466-2474, 1999.
27. + channel associated with idiopathic ventricular fibrillation. Am J Physiol Heart Circ Physiol 280: H354-H360, 2001.